Transkaryotic Therapies Builds Headquarters and Research Facility

Published July 2001

CAMBRIDGE, MASS. -

Transkaryotic Therapies Inc. is building a 185,000-sf headquarters and state-of-the-art laboratory and research facility in an MIT-owned building in Cambridge. The $65 million project, developed by Barr & Barr Inc., involves renovating the existing building, including restoration of the historical building's 150-year-old facade. Copyright 2008 Tradeline Inc.
All Rights Reserved
ISSN: 1096-4894